Sellers S E, Tisdale J F, Agricola B A, Metzger M E, Donahue R E, Dunbar C E, Sorrentino B P
Hematology Branch, the National Heart, Lung, and Blood Institute, and the Molecular and Clinical Hematology Branch, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institutes of Health, Bethesda, MD 20892, USA.
Blood. 2001 Mar 15;97(6):1888-91. doi: 10.1182/blood.v97.6.1888.
Transduction of murine stem cells with a multidrug-resistance 1 gene (MDR1) retrovirus results in dramatic ex vivo and in vivo expansion of repopulating cells accompanied by a myeloproliferative disorder. Given the use of MDR1-containing vectors in human trials, investigations have been extended to nonhuman primates. Peripheral blood stem cells from 2 rhesus monkeys were collected, CD34-enriched, split into 2 portions, and transduced with either MDR1 vectors or neo vectors and continued in culture for a total of 10 days before reinfusion. At engraftment, the copy number in granulocytes was extremely high from both MDR vectors and neo vectors, but the copy number fell to 0.01 to 0.05 for both. There were no perturbations of the leukocyte count or differential noted. After 3 cycles of stem cell factor/granulocyte colony-stimulating factor, there were no changes in the levels of MDR1 vector- or neo vector-containing cells. There was no evidence for expansion of MDR1 vector-transduced cells. Long-term engraftment with MDR1 vector- and neo vector-transduced cells occurred despite prolonged culture.
用多药耐药1基因(MDR1)逆转录病毒转导小鼠干细胞,会导致再植细胞在体外和体内显著扩增,并伴有骨髓增殖性疾病。鉴于含MDR1载体已用于人体试验,研究已扩展到非人类灵长类动物。收集2只恒河猴的外周血干细胞,富集CD34,分成2份,分别用MDR1载体或新霉素载体转导,并在再输注前共培养10天。植入时,MDR载体和新霉素载体转导的粒细胞中的拷贝数都极高,但随后两者的拷贝数均降至0.01至0.05。未发现白细胞计数或分类有异常。经过3个周期的干细胞因子/粒细胞集落刺激因子处理后,含MDR1载体或新霉素载体的细胞水平没有变化。没有证据表明MDR1载体转导的细胞有扩增。尽管培养时间延长,但MDR1载体和新霉素载体转导的细胞仍实现了长期植入。